Acylated piperidine derivatives as melanocortin-4 receptor agonists

Details for Australian Patent Application No. 2002255597 (hide)

International Classifications

Event Publications

6 March 2003 Application Open to Public Inspection

Published as AU-B-2002255597

2 March 2006 Application Accepted

Published as AU-B-2002255597

11 May 2006 Application for Amendment

The nature of the amendment is: Amend the name of the applicant to Merck & Co., Inc. . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

21 September 2006 Change of Name(s) of Applicant(s), Section 104

Merck & Co., Inc.; Ye, Zhixiong The name of the applicant has been changed to Merck & Co., Inc.

28 September 2006 Standard Patent Sealed

26 October 2006 Corrigenda

Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2002255597, under INID (71) delete co-applicant Zhixiong Ye Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2001287382 Ocean Nutrition Canada Limited 2002216844 Future Fibre Technologies Pty Ltd 2003208753 Unilever PLC

21 January 2010 Amendment Made

The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.